Theranostics: Paintball targeting of cancer cells combined with precision therapy

The Journal of Nuclear Medicine’s September supplement shines a spotlight on theranostics and its increasingly important role in delivering precision medicine. Theranostics refers to the combination of a predictive biomarker, identified through diagnostic imaging using radiolabeled ligands (which lock onto the specific cancer cell receptor/biomarker), with precise therapy targeted on the now-marked cancer cells. The cancer cells are destroyed, while healthy cells are unharmed — minimizing side effects and improving quality of life for patients. …read more

Source: EurekAlert

(Visited 3 times, 1 visits today)

Popular Posts